A Biocompatible Arginine-Based Polycation

Self assembly between cations and anions is ubiquitous throughout nature. Important biological structures such as chromatin often use poly­valent assembly between a polycation and a polyanion. The biomedical importance of synthetic polycations arises from their affinity to polyanions such as nucleic...

Full description

Saved in:
Bibliographic Details
Published inAdvanced functional materials Vol. 21; no. 3; pp. 434 - 440
Main Authors Zern, Blaine J., Chu, Hunghao, Osunkoya, Adeboye O., Gao, Jin, Wang, Yadong
Format Journal Article
LanguageEnglish
Published New York WILEY-VCH Verlag 08.02.2011
WILEY‐VCH Verlag
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Self assembly between cations and anions is ubiquitous throughout nature. Important biological structures such as chromatin often use poly­valent assembly between a polycation and a polyanion. The biomedical importance of synthetic polycations arises from their affinity to polyanions such as nucleic acid and heparan sulfate. However, the limited biocompatibility of synthetic polycations hampers the realization of their immense potential. By examining biocompatible cationic peptides, we hypothesize that a biocompatible polycation should be biodegradable and made from endogenous cations. We design an arginine‐based biodegradable polycation and demonstrate that it is more compatible by several orders of magnitude than conventional polycations in vitro and in vivo. This biocompatibility diminishes when L‐arginine is substituted with D‐arginine or when the biodegradable ester linker is changed to a biostable ether linker. We believe that this design can lead to many biocompatible polycations that can significantly advance a wide range of applications including controlled release, tissue engineering, biosensing, and medical devices. The design of PAGS and the control polymers that probe the importance of endogenous cations and their degradability in terms of biocompatibility is studied. The biocompatibility is shown to diminish when L‐arginine is substituted with D‐arginine or when the biodegradable ester linker is changed to a biostable ether linker.
Bibliography:istex:6EBB0DF84B98F298D143C9EAB73FFDE1CE9174F1
ark:/67375/WNG-12K0WRW9-G
ArticleID:ADFM201000969
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1616-301X
1616-3028
1616-3028
DOI:10.1002/adfm.201000969